Tag: Drug revenue

In 2024, overall pharmaceutical expenditures in the U.S. grew by 10.2% to a total of $805.9 billion [1.3.5]. Answering "What is the latest edition of the top 100 drugs?" reveals the key drivers of this spending and major trends in public health.

In 2024, Keytruda (pembrolizumab) dominated global sales, reaching nearly $29.5 billion, showcasing the immense value of specialized, high-cost therapies in the market. But pinpointing exactly what drug sells the most in the USA is not a simple question, as the answer varies significantly depending on whether the measure is total revenue or the sheer number of prescriptions dispensed.

AbbVie's Humira has generated approximately $240 billion in revenue since its launch, making it the highest-grossing drug of all time [1.4.3]. However, the title of 'fastest-selling' is more complex, pitting launch speed against total lifetime sales.